You have 9 free searches left this month | for more free features.

LNA043

Showing 1 - 6 of 6

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Osteoarthritis, Knee Trial in Shinjuku-ku, Osaka (LNA043, Placebo)

Completed
  • Osteoarthritis
  • Knee
  • LNA043
  • Placebo
  • Shinjuku-ku, Tokyo, Japan
  • +1 more
Aug 8, 2022

Wounds and Injuries Trial in Czechia, Denmark, United States (LNA043, Placebo)

Completed
  • Wounds and Injuries
  • LNA043
  • Placebo
  • Phoenix, Arizona
  • +18 more
Jan 24, 2023

Knee Osteoarthritis Trial in Worldwide (canakinumab, LNA043, Placebo to canakinumab)

Recruiting
  • Knee Osteoarthritis
  • canakinumab
  • +2 more
  • Clearwater, Florida
  • +19 more
Dec 14, 2022

Knee Cartilage Lesion Trial in Wien (LNA043, to LNA043)

Terminated
  • Knee Cartilage Lesion
  • LNA043
  • placebo to LNA043
  • Wien, Austria
  • +1 more
Oct 6, 2021

Osteoarthritis Trial in Worldwide (LNA043 Dosing Regimen A, LNA043 Dosing Regimen B, LNA043 Dosing Regimen C)

Recruiting
  • Osteoarthritis
  • LNA043 Dosing Regimen A
  • +4 more
  • Phoenix, Arizona
  • +107 more
Nov 4, 2022

Primary Osteoarthritis Patients Scheduled for Total Knee Replacement Surgery Trial in Phoenix (LNA043, Placebo)

Completed
  • Primary Osteoarthritis Patients Scheduled for Total Knee Replacement Surgery
  • LNA043
  • Placebo
  • Phoenix, Arizona
    Novartis Investigative Site
Dec 9, 2020